They belong to the company because I gave them up when I was employed
A similar conversation is now emerging around obesity medicines: GLP-1 and dual agonists are being recognised internationally as evidence-based treatments for obesity with cardiometabolic benefit.[8] Indian insurers may progressively consider coverage when obesity is severe and linked with diabetes, heart disease, or sleep apnoea, rather than for cosmetic weight loss alone.[10] For families, this could mean negotiating group policies and reading the policy wording carefully to see if medically supervised GLP-1 therapy for obesity-with-complications is covered
Do you just ask a patient about their lifestyle and other things like that to determine if they could potentially have or is there a test that they could do
That is a key distinction from taking synthetic HGH
Green, T., Dow, J., Ellis, M
You will know what to expect in the first few weeks and how your body typically adjusts